Skip to results
Modify your search
NARROW
1-20 of 50
Authors: Jonas Oldgren
Sort by
Journal Article
EDITOR'S CHOICE
Sex differences in prevalence and characteristics of imaging-detected atherosclerosis: a population-based study Open Access
Eva Swahn and others
European Heart Journal - Cardiovascular Imaging, Volume 25, Issue 12, December 2024, Pages 1663–1672, https://doi.org/10.1093/ehjci/jeae217
Published: 19 August 2024
Journal Article
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry Open Access
Linda S Johnson and others
European Heart Journal, Volume 45, Issue 26, 7 July 2024, Pages 2336–2340, https://doi.org/10.1093/eurheartj/ehae319
Published: 04 June 2024
Journal Article
Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure Free
Stefan James and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 2, March 2024, Pages 91–92, https://doi.org/10.1093/ehjcvp/pvad096
Published: 03 January 2024
Journal Article
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation Open Access
Alexander P Benz and others
in
EP Europace
EP Europace, Volume 25, Issue 7, July 2023, euad200, https://doi.org/10.1093/europace/euad200
Published: 18 July 2023
Journal Article
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation Open Access
Ziad Hijazi and others
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 208–218, https://doi.org/10.1093/eurheartj/ehac632
Published: 16 November 2022
Journal Article
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart) Open Access
Gorav Batra and others
European Heart Journal - Quality of Care and Clinical Outcomes, Volume 9, Issue 6, September 2023, Pages 609–620, https://doi.org/10.1093/ehjqcco/qcac068
Published: 15 October 2022
Journal Article
Is the ESC blowing its own trumpet or should it have a deserved fanfare? The impact and power of registry data Free
Mark A de Belder and others
European Heart Journal - Quality of Care and Clinical Outcomes, Volume 8, Issue 8, December 2022, Pages 801–803, https://doi.org/10.1093/ehjqcco/qcac058
Published: 21 September 2022
Journal Article
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference Open Access
Renate B Schnabel and others
in
EP Europace
EP Europace, Volume 25, Issue 1, January 2023, Pages 6–27, https://doi.org/10.1093/europace/euac062
Published: 27 July 2022
Journal Article
OFFICIAL STATEMENT
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society Free
Diana A Gorog and others
in
EP Europace
EP Europace, Volume 24, Issue 11, November 2022, Pages 1844–1871, https://doi.org/10.1093/europace/euac020
Published: 22 March 2022
Journal Article
Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial Open Access
Mate Vamos and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 4, July 2022, Pages 363–371, https://doi.org/10.1093/ehjcvp/pvab090
Published: 27 December 2021
Journal Article
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation Open Access
Tymon Pol and others
Cardiovascular Research, Volume 118, Issue 9, June 2022, Pages 2112–2123, https://doi.org/10.1093/cvr/cvab262
Published: 06 August 2021
Journal Article
Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation Free
Jan Steffel and others
in
EP Europace
EP Europace, Volume 23, Issue 10, October 2021, Page 1676, https://doi.org/10.1093/europace/euab157
Published: 28 June 2021
Journal Article
OFFICIAL STATEMENT
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation Free
Jan Steffel and others
in
EP Europace
EP Europace, Volume 23, Issue 10, October 2021, Pages 1612–1676, https://doi.org/10.1093/europace/euab065
Published: 25 April 2021
Journal Article
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease Free
Alexander P Benz and others
Cardiovascular Research, Volume 118, Issue 1, January 2022, Pages 295–304, https://doi.org/10.1093/cvr/cvaa344
Published: 02 January 2021
Journal Article
EDITOR'S CHOICE
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference Free
Larissa Fabritz and others
in
EP Europace
EP Europace, Volume 23, Issue 3, March 2021, Pages 329–344, https://doi.org/10.1093/europace/euaa279
Published: 29 December 2020
Journal Article
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI Free
Francesco Costa and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 3, May 2022, Pages 216–226, https://doi.org/10.1093/ehjcvp/pvaa135
Published: 01 December 2020
Journal Article
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials Open Access
Giuseppe Gargiulo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f50–f60, https://doi.org/10.1093/ehjcvp/pvaa116
Published: 29 October 2020
Journal Article
EDITOR'S CHOICE
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation Free
Lars Wallentin and others
European Heart Journal, Volume 41, Issue 41, 1 November 2020, Pages 4037–4046, https://doi.org/10.1093/eurheartj/ehaa697
Published: 27 September 2020
Journal Article
Effects of apixaban compared with warfarin as gain in event-free time – a novel assessment of the results of the ARISTOTLE trial Free
Erik Berglund and others
European Journal of Preventive Cardiology, Volume 27, Issue 12, 1 August 2020, Pages 1311–1319, https://doi.org/10.1177/2047487319886959
Published: 01 August 2020
Journal Article
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis Free
Mariëlle Kloosterman and others
in
EP Europace
EP Europace, Volume 22, Issue 6, June 2020, Pages 870–877, https://doi.org/10.1093/europace/euz360
Published: 26 March 2020